ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 167 out of 973

$403K Total Retail Price of All Prescriptions

Rank: 232 out of 973

287 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 287 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,720 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
FUROSEMIDE 488 461 1 6
WARFARIN SODIUM 433 410 2 10
LEVOTHYROXINE SODIUM 432 406 3 2
SIMVASTATIN 392 381 4 1
METOPROLOL TARTRATE 376 369 5 13
AMLODIPINE BESYLATE 346 313 6 7
LISINOPRIL 292 275 7 3
POTASSIUM CHLORIDE 265 251 8 9
LOSARTAN POTASSIUM 221 208 9 19
OMEPRAZOLE 191 190 10 5
METFORMIN HCL 178 151 11 8
HYDROCODONE-ACETAMINOPHEN 173 133 S3 12 4
PRAVASTATIN SODIUM 161 144 13 22
METOPROLOL SUCCINATE 159 146 14 17
CARVEDILOL 159 157 14 27
ATORVASTATIN CALCIUM 140 138 16 15
DONEPEZIL HCL 133 133 17 26
HYDROCHLOROTHIAZIDE 119 119 18 11
TRIAMTERENE-HCTZ 114 90 19 51
ALENDRONATE SODIUM 113 91 20 24
TRAMADOL HCL 107 82 21 18
POLYETHYLENE GLYCOL 3350 107 106 21 36
CITALOPRAM HBR 97 94 23 14
NAMENDA 96 96 24 31
ZETIA 92 77 25 81
PREDNISONE 88 84 26 33
GABAPENTIN 88 85 26 12
NEXIUM 86 73 28 30
SPIRONOLACTONE 85 80 29 49
GLIPIZIDE XL 84 84 30 239
ATENOLOL 78 78 31 16
DIGOXIN 67 59 32 32
CRESTOR 62 61 33 34
NOVOLOG 61 61 34 82
TRAZODONE HCL 60 41 35 48
DIOVAN 54 54 36 63
ROPINIROLE HCL 52 52 37 72
LANTUS 50 50 38 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.